Bookmark
Forward
No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients.
Pedro Dorado, Roland Berecz, Eva M Peñas-Lledó, Alfredo de la Rubia, Adrián Llerena
European journal of clinical pharmacology 2007 May
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Pedro Dorado, Roland Berecz, Eva M Peñas-Lledó, Alfredo de la Rubia, Adrián Llerena.
No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients.
European journal of clinical pharmacology.
2007 May;63(5):527-8
Mesh Tags
Alleles
Antipsychotic Agents
Cytochrome P-450 CYP1A2
Debrisoquin
Dose-Response Relationship, Drug
Genotype
Humans
Mental Disorders
Mesoridazine
Phenothiazines
Polymerase Chain Reaction
Polymorphism, Genetic
Polymorphism, Restriction Fragment Length
Smoking
Thioridazine
Substances
Antipsychotic Agents
Phenothiazines
Debrisoquin
sulforidazine
Thioridazine
Mesoridazine
Cytochrome P-450 CYP1A2
PMID: 17345072
View Full Text